---
title: "Avalo Therapeutics (AVTX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/AVTX.US/norm.md"
symbol: "AVTX.US"
name: "Avalo Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/AVTX.US.md"
datetime: "2026-03-14T00:10:15.505Z"
locales:
  - [en](https://longbridge.com/en/quote/AVTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AVTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AVTX.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/AVTX.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/AVTX.US/norm.md)


# Avalo Therapeutics (AVTX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.19 | -1.92 | -1.25 | -3.44 | -2.83 |
| ROE | -124.92% | -73.12% | -41.15% | -182.53% | 585.11% |
| Revenue | - | - | - | 192000.00 | 249000.00 |
| Net income | -30.63M | -20.77M | -13.15M | -35.16M | 5.46M |
| Operating income | -19.20M | -19.32M | -14.67M | -13.31M | -12.86M |
| Gross margin | - | - | - | -2784.38% | -2508.84% |
| Net margin | - | - | - | -18405.73% | 9251.81% |
| Profit quality | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 125.10M | 126.58M | 138.52M | 150.73M | 98.45M |
| Leverage | 1.37 | 1.21 | 1.13 | 1.13 | 4.33 |
| BVPS | 5.14 | 9.65 | 11.32 | 12.70 | 2.18 |
| Turnover | 0.0017 | 0.0038 | 0.0034 | 0.0051 | 0.0128 |
| Cash & STI | 111.62M | 113.26M | 125.05M | 134.55M | 81.86M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 542000.00 | 686000.00 | 949000.00 | 1.21M | 1.67M |
| Net debt | -111.06M | -112.58M | -124.25M | -133.63M | -80.22M |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -16.36M | -11.39M | -9.46M | -15.04M | -11.53M |
| Investing CF | -13.26M | -70.86M | - | 0.0000 | 0.0000 |
| Financing CF | 14.37M | -469000.00 | - | 67.71M | 0.0000 |
| Free CF | -10.34M | -5.56M | -4.65M | -66.13M | -38.55M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |